Antabio

Antabio is a private biopharmaceutical company developing novel antibacterial resistance breakers for the treatment of drug-resistant infections in areas of highest medical need. It has developed standalone bacterial metalloenzyme inhibitors that can be combined with various antibiotics to restore their activity against the most critical pathogens.Antabio has received the Wellcome Trust Seeding Drug Discovery Award. The company was founded in 2009 and is headquartered in Labege, France.